The PSA test is a blood test that was first introduced to clinical practice to aid in the diagnosis and management of prostate cancer in 1986 and by 1990 it was used in Canada and the USA for prostate cancer screening [31, 32]. The gene discussed is KLK3; the disease is prostate carcinoma.